I would like to know exactly what Biotron has done in relation to Zika and Dengue other than just mention it on their out-of-date web site. The COVID trial doesn't even rate a mention on the Clinical programs page on the website. Your idea of a management spill might be this company's only hope of survival, but I doubt there is enough money in the trough - and hence time - to achieve this. BIT225 might well have a future albeit in the hands of another organisation.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-80
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.14M | |||
| Open | High | Low | Value | Volume |
| 2.0¢ | 2.0¢ | 1.9¢ | $12.80K | 670.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 1054218 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 785473 | 7 |
View Market Depth
| Last trade - 14.54pm 19/11/2024 (20 minute delay) ? |
| BIT (ASX) Chart |